Ophthalmology is experiencing rapid advances in innovation, attracting substantial investment. Join me at #BIO2025 for a panel to discuss:
Improving and Restoring Vision in Blinding Eye Diseases
Tuesday, June 17 | 1:45-2:45 PM ET | Room 254B
More here: https://t.co/DhOB4GUGev
Come by our poster today at #AACR25 to learn about the groundbreaking data from the preclinical program for STX-003 - a systemically delivered self-replicating mRNA encoding IL-12.
Session Details:
Date and Time: April 28, 2:00-5:00 pm CT
Location: Section 37
Big week for @AurionBiotech! Thank you @lisa_stiffler and @geekwire for sharing the exciting news that Aurion received #FDA BTD and RMAT designations for their novel, cell therapy and that CEO Greg Kunst @gdk62 was named @EY_US Entrepreneur of the Year #EOYMTNWEST! More here:
Breaking News: Today Strand announced the first patient was treated with STX-001, a programmable mRNA therapy, in a Phase 1 trial of cancer patients with solid tumors. Read more: https://t.co/PPsHJ5amY4
#FirstPatientDosed#Oncology#ASCO24
Learn about the future of multiplex gene editing and programmable nucleases to cure HIV and other chronic viral infectious diseases in this interview with @ExcisionBio@NucleaseLab and @TMenichiello@_CellandGene
Thanks Tyler Menichiello @_CellandGene. Great to share exciting work at @ExcisionBio: advances in multiplex #GeneEditing & programmable nucleases moving us towards a cure for #HIV and other chronic, viral infectious diseases - #HSV, #HBV and PLM/JCV.
https://t.co/gtLgW0YgEv
@CityMD sent me a bill for $270.00 on Aug. 2022 for a COVID test I took in Nov. 2020. #CityMD submitted a $300.00 insurance claim for the visit and $0 for the test. I'm one of many to get this type of bill. Is this correct? Is it legal? @survivorcorp @NewYorkStateAGO
“But where antibodies stumble, killer Ts shine.”
Get to know the elite fighting forces of your immune system in the latest by @KatherineJWu of @TheAtlantic.
https://t.co/KGtafoxT9W
Preliminary data using @AdaptiveBiotech's immune medicine platform finds that greater than two thirds of the T-cell response to vaccines is on target against the #Omicron variant. New manuscript available here: https://t.co/95Ff0NB6c7
(1/6)
Public health officials are making decisions about COVID-19 vaccinations with incomplete information about immunity. @dramyabernethy and I wrote an op-ed for @morningconsult with recommendations on the path forward.
https://t.co/tJcBs2wo1Q
I said it on stage with @Jonathan_Bush & @GlenTullman & will share it again: Great storytellers have had outsized success in digital health.
A skillset that should not be underestimated.
Just published @NEJM
Neutralizing antibody levels and T cells response out to 8 months for Pfizer, Moderna and J&J vaccines
https://t.co/ghAgk3Y4kR
Moderna highest antibody response; J&J while lower doesn't fall off and best CD8 T-cell response at 8 months
Join us at @DPC_Summit on July 20 at 9 a.m. EDT for a special keynote panel on COVID-19 and the road ahead featuring CSO Harlan Robins and leaders from @WHO, @CDC, @Pfizer and more.
Register at https://t.co/Zj6LC9xoq9.
#DPCSummit#NoMorePandemics
The new Resilience series from our partners @Microsoft explores the role of science and technology in addressing the pandemic & other crises to emerge more resilient into the future. Featuring Adaptive’s @RachelGittelman. https://t.co/UczeETzK6z #SocietalResilience
Join COO Mark Adams at @STATnews Health Tech Summit on Tues. 5/11 at 3:35pm ET as he discusses how understanding T cells could change medicine and the way we diagnose and treat many different diseases. Moderated by @RickBerke. Register: https://t.co/tDYBAKpMdz
We’re honored to announce that T-Detect COVID has been recognized as a finalist in @FastCompany’s 2021 World Changing Ideas Awards with our partners @Microsoft. https://t.co/cWTjb0YY3v
#FCWorldChangingIdeas